Kahrilas Peter J, Carlson Dustin A, Pandolfino John E
Department of Medicine, Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Gastro Hep Adv. 2023;2(5):701-710. doi: 10.1016/j.gastha.2023.02.001. Epub 2023 Feb 9.
High-resolution manometry, Chicago Classification v4.0, the functional lumen imaging probe, Panometry, and peroral endoscopic myotomy (POEM) are all now integral parts of the landscape for managing achalasia or, more precisely, achalasia-like syndromes. This narrative review examines the impact of these innovations on the management of achalasia-like syndromes. High-resolution manometry was the disruptive technology that prompted the paradigm shift to thinking of motility disorders as patterns of obstructive physiology involving the esophagogastric junction and/or the distal esophagus rather than as siloed entities. An early observation was that the cardinal feature of achalasia-impaired lower esophageal sphincter relaxation-can occur in several subtypes: without peristalsis, with pan-esophageal pressurization, with premature (spastic) distal esophageal contractions, or even with preserved peristalsis (esophagogastric junction outlet obstruction). Furthermore, there being no biomarker for achalasia, no manometric pattern is perfectly sensitive or specific for 'achalasia' and there is also no 'gold standard' for the diagnosis. Consequently, complimentary physiological testing with a timed barium esophagram or functional lumen imaging probe are employed both to improve the detection of patients likely to respond to treatments for 'achalasia' and to characterize other syndromes also likely to benefit from achalasia therapies. These findings have become particularly relevant with the development of a minimally invasive technique for performing a tailored esophageal myotomy, POEM. Now and in the future, optimal achalasia management is to render treatment in a phenotype-specific manner, that is, POEM calibrated in a patient-specific manner for obstructive physiology including the distal esophagus and more conservative strategies such as a short POEM or pneumatic dilation for obstructive physiology limited to the lower esophageal sphincter.
高分辨率测压、芝加哥分类法v4.0、功能性管腔成像探头、泛测压法和经口内镜下肌切开术(POEM)现在都是治疗贲门失弛缓症或更确切地说是贲门失弛缓症样综合征的重要组成部分。本叙述性综述探讨了这些创新技术对贲门失弛缓症样综合征治疗的影响。高分辨率测压是一项颠覆性技术,它促使了范式转变,即从将动力障碍视为孤立的实体,转变为将其视为涉及食管胃交界处和/或食管远端的梗阻性生理模式。早期观察发现,贲门失弛缓症的主要特征——食管下括约肌松弛受损——可出现在几种亚型中:无蠕动、全食管加压、远端食管过早(痉挛性)收缩,甚至蠕动保留(食管胃交界处出口梗阻)。此外,由于贲门失弛缓症没有生物标志物,没有任何测压模式对“贲门失弛缓症”具有完全的敏感性或特异性,诊断也没有“金标准”。因此,采用定时钡餐食管造影或功能性管腔成像探头进行补充生理测试,以提高对可能对“贲门失弛缓症”治疗有反应的患者的检测,并对其他可能从贲门失弛缓症治疗中获益的综合征进行特征描述。随着用于进行量身定制的食管肌切开术(POEM)的微创技术的发展,这些发现变得尤为重要。现在和未来,最佳的贲门失弛缓症管理是以表型特异性方式进行治疗,即根据患者特定的梗阻性生理情况进行校准的POEM,包括食管远端,以及针对仅限于食管下括约肌的梗阻性生理情况采用更保守的策略,如短POEM或气囊扩张术。